Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 69 Carcinoma, Non-Small-Cell Lung 62 Stomach Neoplasms 32 Prostatic Neoplasms 21 Nasopharyngeal Carcinoma 20 Lung Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 11 Esophageal Neoplasms 11 Neoplasm Metastasis 8 Head and Neck Neoplasms 7 Inflammatory Breast Neoplasms 6 Pancreatic Neoplasms 5 Neoplasms 5 HER2-positive Breast Cancer 5 Adenocarcinoma 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 NSCLC 4 Carcinoma, Squamous Cell 4 Sarcoma 3 Nasopharyngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Ovarian Epithelial 3 Breast Diseases 3 Adenocarcinoma of Lung 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Squamous Cell Lung Cancer 2

Interventions

Folfox protocol 3 Drug Therapy 3 Cisplatin 3 apatinib 2 anlotinib 2 Paclitaxel 2 Oxaliplatin 2 Fluorouracil 2 Capecitabine 2 sintilimab 1 pyrotinib 1 pemigatinib 1 huachansu 1 donafenib 1 Trastuzumab 1 Sorafenib 1 Radiotherapy 1 Physical Conditioning, Human 1 Microspheres 1 Leucovorin 1 Immune Checkpoint Inhibitors 1 Docetaxel 1 Chemoradiotherapy 1 Bevacizumab 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Digestive System Neoplasms × Docetaxel × Clear all

NCT05262335 2023-11-28

ALTER-G-001

Ruijin Hospital

Phase 2 Unknown

Gastrointestinal

Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡